… and JO18396) of erlotinib in Japanese patients … integrated analysis of these two studies
involving analysis of predictive factors for effect/prognosis in addition to an overview of the safety …

… The oral administration and manageable toxicity of erlotinib, … summarizes safety data from
major clinical trials of erlotinib in … expected with erlotinib in patients with advanced NSCLC. …

… The current study indicated that erlotinib, gefitinib, afatinib and icotinib shared equivalent
efficacy but presented different efficacy-toxicity pattern for EGFR-mutated patients. Erlotinib and …

… erlotinib have certainly been reported in lots of studies and published research. The information
about its safety … meta-analysis is a meaningful and useful approach for erlotinib therapy. …

… treated with erlotinib and they were all evaluated for efficacy and safety in this analysis. Of
… In addition, the efficacy and safety of erlotinib in our patients aged ≥80 and in those aged ≥…

… The EVAN study investigated the efficacy and safety of erlotinib versus vinorelbine/cisplatin
as adjuvant chemotherapy after R0 in patients with stage IIIA NSCLC and epidermal growth …

… to further define the safety of sorafenib and erlotinib, given at … blood monocytes prior to
erlotinib initiation. Epidermal … obtained pretreatment, prior to erlotinib dosing, and during the …

… most common erlotinib-induced AE, rash, and diarrhea, providing insights into erlotinib toxicity.
We used the framework to investigate the safety of high-dose erlotinib pulses proposed to …

… In the RASH study, 150 patients with newly diagnosed metastatic PDAC were treated with
gemcitabine plus erlotinib (gem/erlotinib) for four weeks. Patients who developed a skin rash …

Background The efficacy of bevacizumab combined with erlotinib (B + E) for the treatment of
advanced hepatocellular carcinoma, especially for sorafenib-refractory patients, has been …